Complexity of the microglial activation pathways that drive innate host responses during lethal alphavirus encephalitis in mice

scientific article published on 3 May 2012

Complexity of the microglial activation pathways that drive innate host responses during lethal alphavirus encephalitis in mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1042/AN20120016
P8608Fatcat IDrelease_q3fmu2acqrdtxl5fw5a62qfjdm
P932PMC publication ID3342594
P698PubMed publication ID22471445

P2093author name stringDavid N Irani
Emily K Rainey-Barger
Nilufer Esen
Pennelope K Blakely
P2860cites workFunctional role of type I and type II interferons in antiviral defenseQ24276429
IRF7: activation, regulation, modification and functionQ24299740
Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRsQ24303416
B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5Q24309316
Toll-like receptor signallingQ24570126
A novel Toll-like receptor that recognizes vesicular stomatitis virusQ24622356
UNC93B1 mediates host resistance to infection with Toxoplasma gondiiQ27313711
Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropismQ27469650
Control of Sindbis virus infection by antibody in interferon-deficient miceQ27469654
Antiviral activity of alpha interferon in Sindbis virus-infected cells is restored by anti-E2 monoclonal antibody treatmentQ27480314
The opioid receptor antagonist, naloxone, protects spinal motor neurons in a murine model of alphavirus encephalomyelitisQ27480965
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA virusesQ27860455
Toll-like receptorsQ27860671
Innate immune recognitionQ27860721
The alphaviruses: gene expression, replication, and evolutionQ27860954
Pathogen recognition and innate immunityQ27861084
A chemokine-driven positive feedback loop organizes lymphoid folliclesQ28142202
Herpes simplex virus encephalitis in human UNC-93B deficiencyQ28263759
UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomesQ28270473
The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9Q28292044
A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleenQ28300225
The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signalingQ28590478
Use of Ly6G-specific monoclonal antibody to deplete neutrophils in miceQ81332054
CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitisQ83918246
A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responsesQ33771205
Activation of divergent neuronal cell death pathways in different target cell populations during neuroadapted sindbis virus infection of miceQ33787166
Induction of apoptosis by Sindbis virus occurs at cell entry and does not require virus replication.Q33825385
Lymphoid chemokines in the CNS.Q34020894
Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis.Q34052870
BCL-2 and BAX protect adult mice from lethal Sindbis virus infection but do not protect spinal cord motor neurons or prevent paralysisQ34348333
Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)Q34375520
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study GroupQ34730962
Role of specific innate immune responses in herpes simplex virus infection of the central nervous systemQ35826453
Alphavirus-induced apoptosis in mouse brains correlates with neurovirulence.Q35857229
The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune diseaseQ36537921
Recognition of Staphylococcus aureus-derived peptidoglycan (PGN) but not intact bacteria is mediated by CD14 in microgliaQ36647941
Pathogenesis of encephalitis induced in newborn mice by virulent and avirulent strains of Sindbis virusQ36805448
The inflammatory cytokine, interleukin-1 beta, mediates loss of astroglial glutamate transport and drives excitotoxic motor neuron injury in the spinal cord during acute viral encephalomyelitisQ36965275
Human Toll-like receptor-dependent induction of interferons in protective immunity to virusesQ36990637
Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease.Q37151168
Lymphoid chemokines in chronic neuroinflammationQ37186200
Regulatory molecules required for nucleotide-sensing Toll-like receptorsQ37361434
The role of differential expression of human interferon--a genes in antiviral immunity.Q37571025
Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligandsQ39791660
Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course.Q39808939
Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases.Q41344793
Immunocytochemical identification and quantitation of the mononuclear cells in the cerebrospinal fluid, meninges, and brain during acute viral meningoencephalitisQ42102380
Tumor necrosis factor-alpha modulates glutamate transport in the CNS and is a critical determinant of outcome from viral encephalomyelitisQ42411798
Neuroprotective interventions targeting detrimental host immune responses protect mice from fatal alphavirus encephalitisQ42840679
Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.Q43227358
Glutamate receptor antagonists protect from virus-induced neural degenerationQ43910026
Viral-induced spinal motor neuron death is non-cell-autonomous and involves glutamate excitotoxicity.Q45030474
PRODUCTION OF INTERFERON BY NEWBORN AND ADULT MICE INFECTED WITH SINDBIS VIRUS.Q45714824
Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infectionQ45749972
Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis.Q47357498
Intracerebral cytokine mRNA expression during fatal and nonfatal alphavirus encephalitis suggests a predominant type 2 T cell responseQ48177195
Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.Q48200750
Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research GroupQ48550791
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitmentQ48701331
Isolation of brain parenchymal lymphocytes for flow cytometric analysis. Application to acute viral encephalitisQ48708626
Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis.Q51027456
Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosisQ57912405
Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluidQ59543689
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study GroupQ70650973
Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study GroupQ77573170
P433issue4
P921main subjectencephalitisQ199615
microgliaQ1622829
P304page(s)207-221
P577publication date2012-05-03
P1433published inASN NeuroQ20312578
P1476titleComplexity of the microglial activation pathways that drive innate host responses during lethal alphavirus encephalitis in mice
P478volume4

Reverse relations

cites work (P2860)
Q41809363Activation of intrinsic immune responses and microglial phagocytosis in an ex vivo spinal cord slice culture model of West Nile virus infection
Q37162262An ENU-induced splicing mutation reveals a role for Unc93b1 in early immune cell activation following influenza A H1N1 infection
Q36501695An attenuating mutation in a neurovirulent Sindbis virus strain interacts with the IPS-1 signaling pathway in vivo
Q63246307Arthritogenic Alphavirus-Induced Immunopathology and Targeting Host Inflammation as A Therapeutic Strategy for Alphaviral Disease
Q33731184Buggy Creek virus (Togaviridae: Alphavirus) upregulates expression of pattern recognition receptors and interferons in House Sparrows (Passer domesticus)
Q29198018Chemokine Receptor Ccr7 Restricts Fatal West Nile Virus Encephalitis
Q34992649Differentiation of neurons restricts Arbovirus replication and increases expression of the alpha isoform of IRF-7.
Q36476035Endogenous adaptation to low oxygen modulates T-cell regulatory pathways in EAE.
Q59353759Genetic control of alphavirus pathogenesis
Q47364751Innate immune control of alphavirus infection
Q59350636Interferon regulatory factors 3 and 7 have distinct roles in the pathogenesis of alphavirus encephalomyelitis
Q36494832MicroRNA-34a Negatively Regulates Efferocytosis by Tissue Macrophages in Part via SIRT1
Q37300377Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-l-Norleucine in Mice with Alphavirus Encephalomyelitis
Q33772300Regulated Production of CXCL13 within the Central Nervous System
Q36551188Targeting CXCL13 During Neuroinflammation
Q41487141Unc93b1 -Dependent Endosomal Toll-Like Receptor Signaling Regulates Inflammation and Mortality during Coxsackievirus B3 Infection.

Search more.